Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Cash & Equivalents (2016 - 2025)

Genpact (G) has 17 years of Cash & Equivalents data on record, last reported at $853.8 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 31.71% year-over-year to $853.8 million; the TTM value through Dec 2025 reached $853.8 million, up 31.71%, while the annual FY2025 figure was $853.8 million, 31.71% up from the prior year.
  • Cash & Equivalents reached $853.8 million in Q4 2025 per G's latest filing, up from $740.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.0 billion in Q3 2024 and bottomed at $460.4 million in Q2 2022.
  • Average Cash & Equivalents over 5 years is $687.9 million, with a median of $647.5 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: crashed 43.77% in 2022, then soared 89.03% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $899.5 million in 2021, then fell by 28.09% to $646.8 million in 2022, then dropped by 9.76% to $583.7 million in 2023, then grew by 11.06% to $648.2 million in 2024, then skyrocketed by 31.71% to $853.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $853.8 million in Q4 2025, $740.8 million in Q3 2025, and $663.3 million in Q2 2025.